BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy

JOURNAL ARTICLE published 1 September 2016 in Journal of Clinical Oncology

Authors: Sébastien Héritier | Jean-François Emile | Mohamed-Aziz Barkaoui | Caroline Thomas | Sylvie Fraitag | Sabah Boudjemaa | Florence Renaud | Anne Moreau | Michel Peuchmaur | Catherine Chassagne-Clément | Frédérique Dijoud | Valérie Rigau | Despina Moshous | Anne Lambilliotte | Françoise Mazingue | Kamila Kebaili | Jean Miron | Eric Jeziorski | Geneviève Plat | Nathalie Aladjidi | Alina Ferster | Hélène Pacquement | Claire Galambrun | Laurence Brugières | Guy Leverger | Ludovic Mansuy | Catherine Paillard | Anne Deville | Corinne Armari-Alla | Anne Lutun | Marion Gillibert-Yvert | Jean-Louis Stephan | Fleur Cohen-Aubart | Julien Haroche | Isabelle Pellier | Frédéric Millot | Brigitte Lescoeur | Virginie Gandemer | Christine Bodemer | Roger Lacave | Zofia Hélias-Rodzewicz | Valérie Taly | Frédéric Geissmann | Jean Donadieu